Twelve-month outcomes for heroin dependence treatments: does route of administration matter?

References

• Strang J, Griffiths P, Powis B, Gossop M. Heroin chasers and heroin injectors: differences observed in a community sample in London, UK. Am J Addict 1999; 8: 148–60.
   Google Scholar
• Strang J, Griffiths P, Gossop M. Heroin smoking by ‘chasing the dragon’: origins and history. Addiction 1997; 92: 673–83.
   Google Scholar
• Perez-Jimenez JP, Robert MS. Transitions in the route of heroin use. Eur Addict Res 1997; 3: 93–8.
   Google Scholar
• Smyth BP, O’Brien M, Barry J. Trends in treated opiate misuse in Dublin: the emergence of chasing the dragon. Addiction 2000; 95: 1217–23.
   Google Scholar
• Carpenter MJ, Chutuape MA, Stitzer ML. Heroin snorters versus injectors: comparison on drug use and treatment outcome in age-matched samples. Drug Alcohol Depend 1998; 53: 11–15.
   Google Scholar
• Neaigus A, Miller M, Friedman S et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 2001; 96: 847–60.
   Google Scholar
• Darke S, Topp L, Kaye S, Hall W. Heroin use in New South Wales, Australia, 1996 – 2000: 5-year monitoring of trends in price, purity, availability and use from the Illicit Drug Reporting System (IDRS). Addiction 2002; 97: 179–86.
   Google Scholar
• Swift W, Maher L, Sunjic S, Doan V. Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in South-western Sydney, Aus- tralia. Addiction 1999; 94: 71–82.
   Google Scholar
• Darke S, Hetherington K, Ross J, Lynskey M, Teesson M. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Drug Alcohol Rev 2004; 23: 177–83.
   Google Scholar
• Darke S, Ross J. Fatal heroin overdoses resulting from non- injecting routes of administration, NSW, Australia, 1992 – 1996. Addiction 2000; 95: 596–9.
   Google Scholar
• Gossop M, Griffiths P, Powis B, Williamson S, Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. Brt Med J 1996;313:402.
   PubMed Web of Science ®Google Scholar
• Barrio G, de la Fuente L, Lew C, Royuela L, Bravo MJ, Torrens M. Differences in severity of heroin dependence by route of administration: the importance of length of heroin use. Drug Alcohol Depend 2001; 63: 169–77.
   Google Scholar
• Gossop M, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. Br J Addict 1992; 87: 1527–36.
   Google Scholar
• Dinwiddie SH, Cottler L, Compton W, Abdallah AB. Psychopathology and HIV risk behaviours among injection drug users in and out of treatment. Drug Alcohol Depend 1996; 43: 1–11.
   Google Scholar
• Fuller CM, Vlahov D, Ompad DC, Shah N, Arria A, Strathdee SA. High-risk behaviours associated with transi- tion from illicit non-injection to injection drug use among adolescent and young adult drug users: a case – control study. Drug Alcohol Depend 2002; 66: 189–98.
   Google Scholar
• Kriegstein AR, Shungu DC, Millar WS et al. Leukoence- phalopathy and raised brain lactate from heroin vapor inhalation (chasing the dragon). Neurology 1999; 53: 1765–73.
   Google Scholar
• Buster MCA, Rook L, van Brussel HA, van Ree J, van den Brink W. Chasing the dragon related to impaired lung function among heroin users. Drug Alcohol Depend 2002; 68: 221–8.
   Google Scholar
• Cygan J, Trunsky M, Cobridge T. Inhaled heroin-induced status asthmaticus; five cases and a review of the literature. Chest 2000; 117: 272–5.
   Google Scholar
• Thiblin I, Eksborg S, Petersson A, Fugelstad Rajs, J. Fatal intoxication as a consequence of intranasal administration (snorting) or pulmonary (smoking) of heroin. Forensic Sci Int 2004; 139: 241–7.
   Google Scholar
• Flynn PM, Joe GW, Broome KM, Simpson DD, Brown BS. Recovery from opioid addiction in DATOS. J Subst Abuse Treat 2003; 25: 177–86.
   Google Scholar
• Hser Y, Grella C, Chou CP, Anglin MD. Relationship between drug treatment careers and outcomes: findings from the National Drug Abuse Treatment Outcome Study. Eval Rev 1998; 22: 496–519.
   Google Scholar
• Hubbard R, Marsden M, Rachal J, Harwood H, Cavanaugh E, Ginzburg H. Drug abuse treatment: a national study of effectiveness. Chapel Hill: University of North Carolina Press, 1989.
   Google Scholar
• Joe GW, Broome KM, Simpson DD. Retention and patient engagement in models for different treatment modalities in DATOS. Drug Alcohol Depend 1999; 57: 113–125.
   Google Scholar
• Simpson DD, Joe GW, Brown BS. Treatment retention and follow-up outcomes I. The Drug Abuse Treatment Out- come Study (DATOS). Psych Addict Behav 1997; 4: 294–307.
   Google Scholar
• Darke S, Hall W, Heather N, Wodak A, Ward J. Development and validation of a multi-dimensional instru- ment for assessing outcome of treatment among opioid users: the Opiate Treatment Index. Br J Addict 1992; 87: 593–602.
   Google Scholar
• Ware JE, Kosinski M, Keller SD. A 12 item Short Form health Survey: construction of scales, and preliminary tests of reliability and validity. Med Care 1996; 34: 220–33.
   Google Scholar
• World Health Organization. Composite International Diag- nostic Interview (version 1.1). Vienna: World Health Organization, 1993.
   Google Scholar
• Darke S, Cohen J, Ross J, Hando J, Hall W. Transitions between routes of administration of regular amphetamine users. Addiction 1994; 89: 1077–83.
   Google Scholar
• Ross, J, Lynskey, M, Teesson, M et al. Three month outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS), New South Wales. National Drug and Alcohol Research Centre Technical Report no. 159. Sydney: University of New South Wales, 2003.
   Google Scholar
• SPSS, Inc. SPSS for Windows, 11.0. Chicago: SPSS, Inc., 2001.
   Google Scholar
• Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998; 51: 253 – 63.
   PubMed Web of Science ®Google Scholar